|
| |
Adrenocortical CarcinomaDownload PDF containing detailed information.
Recent Publications on Adrenocortical Carcinoma: |  |
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.
Objective: No standard therapy for advanced adrenocortical carcinoma (ACC)... | 12th November, 2009
| S Wortmann, Dept. of Medicine I, University of Wurzburg, University
| Eur J Endocrinol. 2009 Nov 10.
DOI Direct Link |
Biphasic hormonal responses to the adrenocorticolyticDDT metabolite 3-methylsulfonyl-DDE in human cells.
The DDT metabolite 3-methylsulfonyl-DDE (3-MeSO(2)-DDE) has been proposed... | 11th November, 2009
| Department of Environmental Toxicology, Uppsala University, Sweden.
| Toxicol Appl Pharmacol. 2009 Nov 6.
DOI Direct Link |
Medical management of adrenal disease: a narrative review.
Adrenal diseases comprise for a variety of medical endocrine issues,... | 7th November, 2009
| Department of Endocrinology, E Venizelou Hospital, 2, Athens GR-11521,
| Endocr Regul. 2009 Jul;43(3):127-35.
|
Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.
Abstract A role of beta-catenin (CTNNB1) in the molecular pathogenesis of... | 30th October, 2009
| 1 Faculty of Science, Prince of Songkla University.
| Pediatr Dev Pathol. 2009 Oct 19.
DOI Direct Link |
Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane.
BACKGROUND: A recent nonrandomized interinstitutional study reported that... | 24th October, 2009
| Department of Surgical Oncology, The University of Texas M.D. Anderson
| Ann Surg Oncol. 2009 Oct 23.
DOI Direct Link |
→View more research publications. |
Press Releases About Adrenocortical Carcinoma:
|
 |
| Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting |
17th November, 2009 |
Oncolytics Biotech Inc. |
CALGARY, Nov. 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase I/II U.K.
|
| Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting |
16th November, 2009 |
Oncolytics Biotech Inc. |
CALGARY, Nov. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced that a poster presentation covering updated
|
| Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting |
29th October, 2009 |
Onyx Pharmaceuticals, Inc. |
-- Late Breaker #9
First-in-men Demonstration of Sorafenib Plus TACE for the Treatment of Advanced Hepatocellular Carcinoma (SOCRATES trial)
-- Dr. Andreas Erhardt, Klinik fur
|
| Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma |
19th October, 2009 |
Jennerex, Inc. |
SAN FRANCISCO, Oct. 19 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted
|
| AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago |
29th September, 2009 |
AETERNA ZENTARIS INC. |
Perifosine Continues to Demonstrate Impressive Efficacy, Safety and
Tolerability in Metastatic Renal Cell Carcinoma Patients who Progressed
after Failing Treatment with both a VEGF
|
BioPortfolio Ltd. offers e-mail and postal lists for Adrenocortical Carcinoma scientists - we have details of around 115 individuals working on Adrenocortical Carcinoma .
This page has been viewed 431 times
Recent Search Terms used to find this page: nexavar adrenocortical carcinoma | Trial With Taxotere and Cisplatin in Non-Operable Adrenocortical Carcinoma | estrogen receptor in adrenocortical carcinoma | adrenal carcinoma taxotere | adrenocortical carcinoma book | Systemic chemotherapy for adrenocortical carcinoma comparative responses to conventional first-line therapies | Systemic chemotherapy for adrenocortical carcinoma comparative responses to conventional first-line therapies | Systemic chemotherapy for adrenocortical carcinoma comparative responses to conventional first-line therapies | Systemic chemotherapy for adrenocortical carcinoma comparative responses to conventional first-line therapies | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Adrenocortical Carcinoma across BioPortfolio, or for Adrenocortical Carcinoma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
